LN-665434
Sorafenib Impurity 13 , 0.95 , 583840-04-4
Update time: 2023-04-23
PRODUCT Properties
| InChI | InChI=1S/C20H14ClF3N4O4/c21-16-6-3-12(9-15(16)20(22,23)24)27-19(30)26-11-1-4-13(5-2-11)32-14-7-8-28(31)17(10-14)18(25)29/h1-10H,(H2,25,29)(H2,26,27,30) |
| InChIKey | VYTLLTTWWZIYME-UHFFFAOYSA-N |
| SMILES | C1(C(N)=O)[N+]([O-])=CC=C(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)C=1 |
Description and Uses
N-Desmethyl Sorafenib (Pyridine)-N-oxide is a metabolite of Sorafenib (S676850) and has anti-proliferative activity in human breast cancer cells.
